Steatohepatitis/Metabolic Liver Disease

Top Story

Marshall University joins AURORA study for late-stage NASH treatment

March 14, 2019

Lipocine fatty liver therapy leads to high rates of NAFLD resolution

March 12, 2019
LPCN 1144 significantly reduced liver fat in patients with nonalcoholic fatty liver disease after 16 weeks, according to a press release from the manufacturer, Lipocine…

Amsety joins Fatty Liver Foundation for liver health awareness campaign

March 11, 2019
Amsety and the Fatty Liver Foundation announced the launch of the “Kiss and Click” campaign designed to raise awareness about fatty liver disease and liver…

Poll shows most Canadians unaware of NAFLD risks, outcomes

March 6, 2019
Results from an online survey conducted by the Canadian Liver Foundation revealed that 56% of Canadians were unaware that nonalcoholic fatty liver disease can lead to…
More Headlines »

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

Expert reviews clinical liver disease take-aways from DDW 2018

June 5, 2018
More »
Healio Jobs